ATE83376T1 - Chinolinylaether tetrazole als mittel zur behandlung von hyperempfindlichen krankheiten. - Google Patents

Chinolinylaether tetrazole als mittel zur behandlung von hyperempfindlichen krankheiten.

Info

Publication number
ATE83376T1
ATE83376T1 AT87902015T AT87902015T ATE83376T1 AT E83376 T1 ATE83376 T1 AT E83376T1 AT 87902015 T AT87902015 T AT 87902015T AT 87902015 T AT87902015 T AT 87902015T AT E83376 T1 ATE83376 T1 AT E83376T1
Authority
AT
Austria
Prior art keywords
tetrazoles
treatment
medication
hypersensitive
quinolinyl ether
Prior art date
Application number
AT87902015T
Other languages
English (en)
Inventor
Raymond Youssefyeh
Utpal Chakraborty
Ernest Magnien
Rohit Desai
Thomas D-Y Lee
Original Assignee
Rhone Poulenc Rorer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/839,410 external-priority patent/US4839369A/en
Priority claimed from US06/911,028 external-priority patent/US4868193A/en
Application filed by Rhone Poulenc Rorer Int filed Critical Rhone Poulenc Rorer Int
Application granted granted Critical
Publication of ATE83376T1 publication Critical patent/ATE83376T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/20—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hydrogen atoms and substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D309/22—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT87902015T 1986-03-13 1987-03-11 Chinolinylaether tetrazole als mittel zur behandlung von hyperempfindlichen krankheiten. ATE83376T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/839,410 US4839369A (en) 1985-04-16 1986-03-13 Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US06/911,028 US4868193A (en) 1986-09-24 1986-09-24 Styryl tetrazoles and anti-allergic use thereof
EP87902015A EP0260305B1 (de) 1986-03-13 1987-03-11 Chinolinyläther tetrazole als mittel zur behandlung von hyperempfindlichen krankheiten
PCT/US1987/000560 WO1987005510A1 (en) 1986-03-13 1987-03-11 Quinolinyl ether or thioether tetrazoles as agents for the treatment of hypersensitive ailments

Publications (1)

Publication Number Publication Date
ATE83376T1 true ATE83376T1 (de) 1993-01-15

Family

ID=27126105

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87902015T ATE83376T1 (de) 1986-03-13 1987-03-11 Chinolinylaether tetrazole als mittel zur behandlung von hyperempfindlichen krankheiten.

Country Status (7)

Country Link
EP (1) EP0260305B1 (de)
JP (1) JPS63503139A (de)
AT (1) ATE83376T1 (de)
AU (1) AU612569B2 (de)
CA (1) CA1324142C (de)
DE (1) DE3783105T2 (de)
WO (1) WO1987005510A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962203A (en) * 1985-06-18 1990-10-09 Merck Frost Canada, Inc. 2-substituted quinolines useful as leukotriene antagonists
MA20977A1 (fr) * 1986-05-19 1987-12-31 Ciba Geigy Ag Plantes tolerant les herbicides contenant le gene de gluthathione S-Transferase
EP0271287A3 (de) * 1986-12-11 1990-06-13 Merck Frosst Canada Inc. Chinolindicarbonsäuren und ihre Amide
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4920133A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4920130A (en) * 1987-11-02 1990-04-24 Rorer Pharamceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4920131A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
EP0318093A3 (de) * 1987-11-25 1990-12-05 Merck Frosst Canada Inc. Diarylchinolindicarbonsäure und ihre Verwendung als Arzneimittel
US5104882A (en) * 1987-11-25 1992-04-14 Merck Frosst Canada, Inc. Diarylstrylquinoline diacids and pharmaceutical compositions thereof
US5204358A (en) * 1987-11-25 1993-04-20 Merck Frosst Canada, Inc. Hetaryl styryl quinolines as leukotriene inhibitors
US5232916A (en) * 1988-06-27 1993-08-03 Merck Frosst Canada, Inc. Quinoline ether alkanoic acids
ZA894913B (en) * 1988-07-12 1990-03-28 Ici Pharma Heterocyclic compounds
US5089495A (en) * 1989-01-30 1992-02-18 Imperial Chemical Industries Plc Heterocyclic thiazole derivatives and pharmaceutical compositions comprising said derivatives
DE69016125T2 (de) * 1989-08-11 1995-06-01 Zeneca Ltd Chinolin-Derivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel.
FR2665159B1 (fr) * 1990-07-24 1992-11-13 Rhone Poulenc Sante Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent.
US5246944A (en) * 1991-08-13 1993-09-21 Merck & Co., Inc. Quinoline angiotensin ii antagonists incorporating a substituted benzyl element
DE4129742A1 (de) * 1991-09-06 1993-03-11 Bayer Ag Heterocyclisch substituierte chinolylmethoxy-phenylacetamide
ES2287016T3 (es) 1999-04-28 2007-12-16 Sanofi-Aventis Deutschland Gmbh Derivados de diaril-acido como ligandos del receptor ppar.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202985A (en) * 1978-10-25 1980-05-13 E. R. Squibb & Sons, Inc. Imidazolylethoxy derivatives of quinoline-3-methanols
US4474788A (en) * 1981-11-12 1984-10-02 Fisons Plc Anti-SRSA quinoline carboxylic acid derivatives
US4839369A (en) * 1985-04-16 1989-06-13 Rorer Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4661499A (en) * 1985-06-18 1987-04-28 Merck Frosst Canada, Inc. 2-[(substituted)-phenoxymethyl]quinolines

Also Published As

Publication number Publication date
EP0260305B1 (de) 1992-12-16
DE3783105T2 (de) 1993-04-22
DE3783105D1 (de) 1993-01-28
AU612569B2 (en) 1991-07-18
WO1987005510A1 (en) 1987-09-24
CA1324142C (en) 1993-11-09
EP0260305A4 (de) 1988-07-04
EP0260305A1 (de) 1988-03-23
JPS63503139A (ja) 1988-11-17
AU7162387A (en) 1987-10-09

Similar Documents

Publication Publication Date Title
ATE83376T1 (de) Chinolinylaether tetrazole als mittel zur behandlung von hyperempfindlichen krankheiten.
DE3855501D1 (de) Chinolin-derivate als antagonisten von leukotrien d 4?
IS4073A (is) Nýtt fjölvirknislyf gegn aukningu mótstöðu
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
DE69507029T2 (de) Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin-vermittelten krankheiten
EE03969B1 (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
NO308794B1 (no) Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
ATE334668T1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
ATE119520T1 (de) Derivate von hydroxaminsäure und von n- hydroxyharnstoff sowie ihre verwendung.
DE3774918D1 (de) Cancerostatisches mittel.
DK678887D0 (da) Farmaceutiske praeparater
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
DE60136826D1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
NO166939C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive carboxylsyrederivater.
ATE158183T1 (de) Arzneimittel zur behandlung von anxietas
EP0532705A1 (de) Chinolinyl-benzoheterocyclische derivate als leukotrien d4 antagonisten
FR2755965B1 (fr) Composes biaromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
BR0115883A (pt) Derivados de ácido amino-furan-2-il-acético e ácido amino-tien-2-il-acético substituìdos e seu emprego para o tratamento de cefaléia ou dor
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
TR200100637T2 (tr) Yeni doğal ürün türevleri
DE69125940D1 (de) Pharmazeutische zusammensetzungen die 5-difluormethoxy-2-[3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1h-benzimidazol und ein anti-heliobactermittel enthalten zur behandlung von magen-darm krankheiten
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
NO995838L (no) Nye heteroetynylenforbindelser og farmasoeytiske og kosmetiske preparater inneholdende de samme